Avricore Health Inc.
Close on Oct 16, 2026
About Avricore Health
Pharmaceutical Preparations, SIC 2834
Avricore Health Inc. is a healthcare technology company focused on acquiring and developing early-stage technologies for the pharmacy sector. Its core offering is HealthTab, a turnkey point-of-care testing platform designed to deliver lab-accurate diagnostic testing services within community pharmacies. Operating primarily through point-of-care technology and system analyzer offerings, the company serves pharmacy chains, independent pharmacy operators, healthcare providers, and the patients who receive point-of-care diagnostic testing.
The company operates in Canada and has begun expanding its market presence into the United Kingdom. Its testing platform has been deployed across hundreds of community retail pharmacy locations, including nationwide distribution through major Canadian drugstore chains. Avricore Health Inc. is incorporated in British Columbia, Canada, and maintains its principal executive offices and headquarters in Vancouver, British Columbia.
Summary of the business section of Avricore Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Avricore Health Inc.
- Founded
- 1996
- Headquarters
- Vancouver, A1
- Address
- 789 West Pender Street, Suite 810 V6C 1H2
- Phone
- (604) 687-2038
- Website
- avricorehealth.com
- Employees
- 1, Dec 31, 2024
- Industry
- Pharmaceutical Preparations
- Incorporated in
- A1
- Fiscal year ends
- December 31
- Auditor
- Manning Elliott LLP, Vancouver, Canada
Stock & identifiers
- Ticker
- AVCRF
- IPO date
- Jun 18, 2009
- Shares outstanding
- 101M, Dec 31, 2024
- Filer category
- Non-accelerated filer
- Stock splits
- 1-for-4 reverse, Nov 21, 2016; 1-for-10 reverse, Mar 8, 2012
- SEC CIK
- 1355736
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Avricore Health's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“As of December 31, 2024, the Company employed 1 employee.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Oct 5, 2018 | Name change | Name changed from Vanc Pharmaceuticals Inc. to Avricore Health Inc. |
| Apr 30, 2018 | Late filing | Notification of late filing |
| Oct 29, 2015 | Late filing | Notification of late filing |
| Jun 17, 2014 | Name change | Name changed from NUVA Pharmaceuticals Inc. to Vanc Pharmaceuticals Inc. |
| Oct 29, 2013 | Name change | Name changed from ALDA Pharmaceuticals Corp. to NUVA Pharmaceuticals Inc. |
| Dec 29, 2011 | Late filing | Notification of late filing |